Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,686 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −13.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03500367	Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis	unknown	Phase 4	25	Peking Union Medical College HospitalOTHER	1	Apr 18, 2018	clinicaltrials
NCT01669369	Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma(Li2CO3)	unknown	Phase 4	400	Sun Yat-sen UniversityOTHER	1	Nov 1, 2016